Cargando…
Is platelet activating factor (PAF) an important mediator in bronchial asthma?
The development of selective PAF receptor antagonists may provide a novel approach to the treatment of human bronchial asthma. In preclinical animal models of human asthma, PAF receptor antagonists have been found to be efficacious in blocking antigen-induced changes in lung function. However, the m...
Autores principales: | Gundel, R. H., Heuer, H. O., Letts, L. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365369/ https://www.ncbi.nlm.nih.gov/pubmed/18475485 http://dx.doi.org/10.1155/S0962935192000541 |
Ejemplares similares
-
A PAF receptor antagonist inhibits acute airway inflammation and late-phase responses but not chronic airway inflammation and hyperresponsiveness in a primate model of asthma
por: Gundel, R. H., et al.
Publicado: (1992) -
Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR
por: Deng, Meng, et al.
Publicado: (2019) -
Platelet-Activating Factor (PAF) in Allergic Rhinitis: Clinical and Therapeutic Implications
por: Muñoz-Cano, Rosa M., et al.
Publicado: (2019) -
Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer
por: Souza, Juliana L., et al.
Publicado: (2020) -
Activation of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. II. The role of serine proteases, cyclic nucleotides, and contractile elements in PAF-induced secretion
Publicado: (1976)